Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4) - Dataset (ID:20276)
- Detail
- Small Molecules Studied
- Cell Lines Studied
- Proteins Studied
- Antibodies Studied
- Data Columns
- Results
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10282-2 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 | 5311 | |
10328-1 | (+)-JQ1 | (S)-JQ1 | LSM-6332 | 46907787 | |
10313-1 | Pracinostat | SB939 | LSM-43290 | 56603532 | |
10310-1 | Belinostat | PXD101 | LSM-43181 | 53437714 | |
10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 | 42611257 | |
10311-1 | Entinostat | MS-275; MS-27-275 | LSM-4811 | 4261 | |
10312-1 | Mocetinostat | MGCD0103 | LSM-5344 | 9865515 | |
10325-1 | Methylstat | luo2011_cmpd2 | LSM-43292 | ||
10330-1 | I-BET | GSK 525762A | LSM-6334 | 46943432 | |
10331-1 | I-BET151 | GSK1210151A | LSM-6335 | 52912189 | |
10316-1 | Selisistat | EX-527; SEN196 | LSM-6271 | 707029 | |
10336-1 | Epigallocatechin gallate | EGCG | LSM-5661 | 65064 | |
10303-1 | Iniparib | BSI 201 | LSM-6317 | 9796068 | |
10144-2 | Olaparib | AZD2281; KU-0059436 | LSM-1145 | 23725625 | |
10304-1 | Rucaparib | AG014699; PF-01367338 | LSM-4947 | 9931954 | |
10315-1 | Rocilinostat | ACY-1215 | LSM-6324 | 53340666 | |
10145-1 | Veliparib | ABT-888 | LSM-1146 | 11960529 | |
10300-1 | Azacitidine | 5-azacytidine; Vidaza; AZA | LSM-5218 | 9444 | |
10301-1 | Decitabine | 5-aza-2'-deoxycytidine; Dacogen; DAC | LSM-5855 | 451668 | |
10326-1 | Tranylcypromine | 2-PCPA | LSM-5578 | 19493 | |
10334-1 | UNC1215 | LSM-6338 | 57339144 | ||
10335-1 | IOX2 | LSM-6339 | 54685215 | ||
10339-1 | CX-5461 | LSM-6342 | 25257557 | ||
10302-1 | RG-108 | LSM-6283 | 702558 | ||
10305-1 | JW55 | LSM-6318 | 2946601 |